BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 30578360)

  • 1. Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV
    Kronborg T; Hangaard S; Cichosz SL; Hejlesen O
    Respir Care; 2019 Jan; 64(1):85-90. PubMed ID: 30578360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can spirometric norms be set using pre- or post- bronchodilator test results in older people?
    Kato B; Gulsvik A; Vollmer W; Janson C; Studnika M; Buist S; Burney P
    Respir Res; 2012 Nov; 13(1):102. PubMed ID: 23157675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
    Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B
    Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
    Richter DC; Joubert JR; Nell H; Schuurmans MM; Irusen EM
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):693-9. PubMed ID: 19281083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Implications of Bronchodilator Testing: Diagnosing and Differentiating COPD and Asthma-COPD Overlap.
    Annangi S; Coz-Yataco AO
    Respir Care; 2022 Apr; 67(4):440-447. PubMed ID: 35338095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 7. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.
    Papi A; Hughes R; Del Olmo R; Agusti A; Chipps BE; Make B; Tomaszewski E; Peres Da Costa K; Srivastava D; Vestbo J; Janson C; Burgel PR; Price D
    Ther Adv Respir Dis; 2024; 18():17534666241254212. PubMed ID: 38841799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.
    Lundgren FL; Cabral MM; Clímaco DC; de Macedo LG; Coelho Mde A; Dias AL
    J Bras Pneumol; 2007; 33(2):148-51. PubMed ID: 17724533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of heart failure on the classification of COPD severity.
    Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
    J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FEV1/FEV6 is effective as a surrogate for FEV1/FVC in the diagnosis of chronic obstructive pulmonary disease.
    Venkatachalam P; Dwivedi DP; Govindraj V
    Indian J Tuberc; 2021 Apr; 68(2):230-235. PubMed ID: 33845957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Subjects With Undiagnosed COPD Based on Post-Bronchodilator Spirometry Data.
    Hangaard S; Kronborg T; Hejlesen OK
    Respir Care; 2019 Jan; 64(1):63-70. PubMed ID: 30087194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study.
    van den Bemt L; Wouters BC; Grootens J; Denis J; Poels PJ; Schermer TR
    NPJ Prim Care Respir Med; 2014 Aug; 24():14033. PubMed ID: 25119686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand.
    Holt NR; Thompson BR; Miller B; Borg BM
    Intern Med J; 2019 Jan; 49(1):41-47. PubMed ID: 30043534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study.
    Tan DJ; Lodge CJ; Walters EH; Bui DS; Pham J; Lowe AJ; Bowatte G; Vicendese D; Erbas B; Johns DP; James AL; Frith P; Hamilton GS; Thomas PS; Wood-Baker R; Han MK; Washko GR; Abramson MJ; Perret JL; Dharmage SC
    Am J Respir Crit Care Med; 2024 Jun; 209(12):1431-1440. PubMed ID: 38236192
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-bronchodilator spirometry reference values in adults and implications for disease management.
    Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.